Waverley Pharma Third Quarter 2022 Earnings: CA$0.002 loss per share (vs CA$0.004 loss in 3Q 2021)

  • In Business
  • 2022-11-26 12:35:00Z
  • By Simply Wall St.

Waverley Pharma (CVE:WAVE) Third Quarter 2022 Results

Key Financial Results

  • Revenue: CA$341.9k (down 11% from 3Q 2021).

  • Net loss: CA$121.7k (loss narrowed by 41% from 3Q 2021).

  • CA$0.002 loss per share (improved from CA$0.004 loss in 3Q 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Waverley Pharma's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Waverley Pharma (3 make us uncomfortable) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here


More Related News

Some Confidence Is Lacking In Hong Leong Capital Berhad
Some Confidence Is Lacking In Hong Leong Capital Berhad's (KLSE:HLCAP) P/E

When close to half the companies in Malaysia have price-to-earnings ratios (or "P/E's") below 13x, you may consider...

Yenher Holdings Berhad
Yenher Holdings Berhad's (KLSE:YENHER) one-year earnings growth trails the shareholder returns

If you want to compound wealth in the stock market, you can do so by buying an index fund. But one can do better than...

Vinvest Capital Holdings Berhad
Vinvest Capital Holdings Berhad's (KLSE:VINVEST) earnings trajectory could turn positive as the stock jumps 12% this past week

Vinvest Capital Holdings Berhad ( KLSE:VINVEST ) shareholders will doubtless be very grateful to see the share price up...

Securities fraud trial over Elon Musk
Securities fraud trial over Elon Musk's 2018 tweets draws to a close
  • US
  • 2023-02-03 11:07:52Z

A lawyer for Tesla Inc shareholders who claim Elon Musk deceived them when he tweeted that he had secured funding to take his electric car company private is...

Jarvis Securities (LON:JIM) shareholders have endured a 42% loss from investing in the stock a year ago
Jarvis Securities (LON:JIM) shareholders have endured a 42% loss from investing in the stock a year ago

The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: Business